Presentation is loading. Please wait.

Presentation is loading. Please wait.

A Guide to the Scientific Registry of Transplant Recipients Organ Procurement Organization Reports www.srtr.org www.srtr.org.

Published byKathryn Bryant Modified over 9 years ago

Similar presentations

Presentation on theme: "A Guide to the Scientific Registry of Transplant Recipients Organ Procurement Organization Reports www.srtr.org www.srtr.org."— Presentation transcript:

1 A Guide to the Scientific Registry of Transplant Recipients Organ Procurement Organization Reports www.srtr.org www.srtr.org

2 Conceptual Framework for OPO Measures OPOs can be assessed for performance at several points during the organ procurement process. Steps are discussed in the following slides, including the current state of development of each metric and data limitations.

3 Step 1: Identify Eligible Deaths Metric:  Eligible deaths per notifiable death. Development:  Historically available on the SRTR website with comparisons to expected rates before January 2008. Limitations:  Eligible deaths historically self-reported aggregate counts.

4 Step 2: Convert Eligible Deaths to Donors Metric:  Donors per eligible death. Development:  Historically available on the SRTR website with comparison to expected rates (not in January 2008). Limitations  Eligible deaths are currently self-reported aggregate counts.  Does not include DCD or donors aged > 70 years.  Current models for “expected” donation rates are limited to information about the hospitals where the deaths occurred, which is not much better than crude rates.  Models will likely be improved by accounting for the characteristics of individual eligible deaths (data to be collected by the OPTN beginning January 9, 2008).  Specific underlying adjustment data from AHA cannot be shared. Alternative sources are being explored.

5 Step 3: Recovered and Transplanted Organs Metric:  Organs recovered and transplanted per donor. Development:  Crude rates available on the SRTR website, stratified by donor type.  Methods for modeling an expected yield per donor are under consideration. Limitations:  Statistical test is not straightforward for the combined observed vs. expected yield because recovery of different organs from the same donor are not independent events.  Multiple factors, including factors external to the OPO, influence this outcome.

6 www.srtr.org TableDescription 1Organs recovered and transplanted per donor 2Centers transplanting organs/exports 3Adjusted measures of donation rates, DSA 3AAdjusted measures of donation rates, hospital 4Donor characteristics 5Donor characteristics by organ 6Percent undergoing transplant, waitlisted patients 7Time to transplant, waitlisted patients 8Recipient characteristics 9Coverage area: Counties assigned to DSA

7 Table 1: Organs Recovered/Transplanted per Deceased Donor N and % of recovered (and transplanted) organs or donors per donor type.  includes organs exported to other DSAs.  segmented organs may count for more than one transplant (n transplants may be > n recovered). National averages. Separate reporting by donor type (instead of adjustment). “Donors”: at least one organ recovered for transplant.

8 This DSAUS DonorsOrgans RecoveredTransplantedRec.Transplanted CountPer Donor type CountPer Donor type CountPer Donor Type % TXPer Donor Type % TX All Donors239/239=100.07933.326642.7883.73.523.0987.7 Intestine60.036 6 1000.02 89.8 Kidney2040.854081.713331.3981.61.771.4984.1 Pancreas430.18430.18350.1581.40.270.2177.1 Liver2080.872080.871750.7384.10.880.8293.1 Lung290.12550.23480.287.30.270.2695.9 Heart730.31730.31690.2994.50.3 98.4 793 organs recovered from 239 donors

9 This DSAUS DonorsOrgans RecoveredTransplantedRec.Transplanted CountPer Donor type CountPer Donor type CountPer Donor Type % TXPer Donor Type % TX All Donors239/239=100.07933.326642.7883.73.523.0987.7 Intestine60.036 6 1000.02 89.8 Kidney2040.854081.713331.3981.61.771.4984.1 Pancreas430.18430.18350.1581.40.270.2177.1 Liver2080.872080.871750.7384.10.880.8293.1 Lung290.12550.23480.287.30.270.2695.9 Heart730.31730.31690.2994.50.3 98.4 = 3.32 organs recovered per donor

10 This DSAUS DonorsOrgans RecoveredTransplantedRec.Transplanted CountPer Donor type CountPer Donor type CountPer Donor Type % TXPer Donor Type per Donor Type % TX All Donors239/239=100.07933.326642.7883.73.523.0987.7 Intestine60.036 6 1000.02 89.8 Kidney2040.854081.713331.3981.61.771.4984.1 Pancreas430.18430.18350.1581.40.270.2177.1 Liver2080.872080.871750.7384.10.880.8293.1 Lung290.12550.23480.287.30.270.2695.9 Heart730.31730.31690.2994.50.3 98.4 664 organs transplanted from 239 donors

11 This DSAUS DonorsOrgans RecoveredTransplantedRec.Transplanted CountPer Donor type CountPer Donor type CountPer Donor Type % TXPer Donor Type % TX All Donors239/239=100.07933.326642.7883.73.523.0987.7 Intestine60.036 6 1000.02 89.8 Kidney2040.854081.713331.3981.61.771.4984.1 Pancreas430.18430.18350.1581.40.270.2177.1 Liver2080.872080.871750.7384.10.880.8293.1 Lung290.12550.23480.287.30.270.2695.9 Heart730.31730.31690.2994.50.3 98.4 = 2.78 transplanted organs per donor

12 This DSAU.S. DonorsOrgans RecoveredTransplantedRec.Transplanted CountPer Donor type CountPer Donor type CountPer Donor Type % TXPer Donor Type % TX All Donors239/239=100.07933.326642.7883.73.523.0987.7 Intestine60.036 6 1000.02 89.8 Kidney2040.854081.713331.3981.61.771.4984.1 Pancreas430.18430.18350.1581.40.270.2177.1 Liver2080.872080.871750.7384.10.880.8293.1 Lung290.12550.23480.287.30.270.2695.9 Heart730.31730.31690.2994.50.3 98.4 664/793 (83.7%) of organs recovered were transplanted

13 This DSAUS DonorsOrgans RecoveredTransplantedRec.Transplanted CountPer Donor type CountPer Donor type CountPer Donor Type % TXPer Donor Type % TX All Donors239/239=100.07933.326642.7883.73.523.0987.7 Intestine60.036 6 1000.02 89.8 Kidney2040.854081.713331.3981.61.771.4984.1 Pancreas430.18430.18350.1581.40.270.2177.1 Liver2080.872080.871750.7384.10.880.8293.1 Lung290.12550.23480.287.30.270.2695.9 Heart730.31730.31690.2994.50.3 98.4 All of the statistics from this DSA were lower than the US averages

14 Reporting by Donor Types Heart-beating.  SCD: standard criteria donor. Aged younger than 60 years and not DCD or ECD.  ECD: expanded criteria donor (KI-donor type). Heart-beating donors aged older than 60 years and aged between 50 and 59 years meeting 2 of the following 3 conditions: died of stroke, history of hypertension, serum creatinine > 1.5 mg/dL. Non-heart beating.  DCD: donation after cardiac death.

15 Table 3: Measures of Donation Rates: Two Processes Notifiable deaths: DSA-wide in-hospital deaths of patients aged 0-70 years with no exclusionary medical diagnosis for possible donation, † mean 5.4 (eligible deaths per 100 notifiable deaths). Eligible deaths * : OPO-reported aggregate eligible deaths from hospitals (excludes cardiac deaths). Deceased donors: at least 1 organ recovered. * Eligible: Aged 0-70 years, death by neurological criteria, no exclusionary medical conditions. † Ojo AO, et al. A practical approach to evaluate the potential donor pool and trends in cadaveric kidney donation. Transplantation 1999; 67:548-566. Donation Rate: Deceased Donors Eligible Deaths * Notification Rate: Eligible Deaths * Notifiable Deaths, DSA and

16 Crude (Observed) Donation Rate Eligible deaths.  OPTN definition (heart-beating, aged < 71 years, acceptable cause of death). Eligible donors (subset of eligible deaths).  Aged < 71 years and not DCD becoming donors. Crude donation rate.  100 * eligible donors/eligible deaths. Additional donors.  Not eligible deaths.  Aged > 70 years plus DCD.

17 This DSA/OPOAverage Observed donation measures Deceased donors (all)162138 Deceased donors meeting eligibility criteria135121 Additional donors (aged > 70 years, DCD)2717 Eligible deaths232190 Crude donation rate 1 (donors per 100 eligible deaths)58.263.7 Crude organ-specific rates 2 (organs per 100 eligible deaths) Kidney53.057.5 Liver54.757.0 Heart17.720.6 Lung7.811.9 Pancreas19.017.7 135 eligible donors/232 eligible deaths = 58% donation rate.

18 This DSA/OPOAverage Observed donation measures Deceased donors (all)162138 Deceased donors meeting eligibility criteria135121 Additional donors (aged > 70 eyars, DCD)2717 Eligible deaths232190 Crude donation rate 1 (donors per 100 eligible deaths)58.263.7 Crude organ specific rates 2 (organs per 100 eligible deaths) Kidney53.057.5 Liver54.757.0 Heart17.720.6 Lung7.811.9 Pancreas19.017.7 27 additional donors not included in the donation rate calculations.

19 Percentage of Additional Donors * Among All Deceased Donors by OPO * Donors aged >70 years and donors after cardiac death not currently included in SRTR conversion calculations.

20 Average Conversion and Discard Rates for All OPOs 2002-2006 HRSA collaboratives began in April 2003. Source: SRTR analysis, August 2007.

21 Adjustments Used for Expected Rates Notification rate: age, sex, race, and cause of death. Source: NCHS Population Death Record Donation rate 1: trauma center, MSA size, CMS case mix index, total bed size, ICU beds, children’s hospital, resident training program, neurological services, hospital control/ownership. Source: AHA Survey. Donation rate 2: as above, plus notification rate.

22 Standardized Donation Rate Model “What donation rate would we expect for this DSA, given the characteristics of the hospitals in its service area?”  Trauma center, MSA size, CMS case mix index, total bed size, ICU beds, neurological service, resident training program, children’s hospital, hospital control/ownership. Source: AHA Survey ASDR = SDR with an adjustment for notifiable deaths. Standardized ratio: observed rate/expected rate. Statistical comparisons:  Compare observed to expected counts, 2-sided p-value.  95% confidence limits for standardized ratio.

23 How to Compare Crude Rates to Expected Rates Measure of DonationObservedExpected 5,6,7 p-value 8 Notification rate (eligible deaths per 100 notifiable deaths) 5.34.60.339 Donation rate (hospital characteristics) 6 58.265.90.043 Kidney-specific rate53.059.50.102 Liver-specific rate54.758.70.316 Heart-specific rate17.719.50.514 Lung-specific rate7.810.50.161 Pancreas-specific rate19.017.60.592 Almost 8 fewer organs were recovered than expected. Given the characteristics of the hospitals in this DSA, this difference is significantly lower than expected.

24 This DSA/OPOStandardized 95% Confidence Interval 10 Measure of Donation ObservedExpected 5,6,7 P-value 8 Ratio 9 LowerUpper Notification rate 5.34.60.3391.151.160.86 Donation rate (hospital) 58.265.90.0430.88 0.78 Kidney-specific rate53.059.50.1020.89 0.78 Liver-specific rate54.758.70.3160.93 0.82 Heart-specific rate17.719.50.5140.91 0.67 Lung-specific rate7.810.50.1610.74 0.44 Pancreas-specific rate19.017.60.5921.08 0.80 The observed donation rate is 12% lower than the expected donation rate.

25 This DSA/OPO Measure of donationObservedExpected 5,6,7 P-value 8 Notification rate (eligible deaths per 100 notifiable deaths) 5.34.60.339 Donation rate (hospital characteristics) 6 58.265.90.043 Kidney-specific rate53.059.50.102 Liver-specific rate54.758.70.316 Heart-specific rate17.719.50.514 Lung-specific rate7.810.50.161 Pancreas-specific rate19.017.60.592 Donation rate (hospital characteristics, notification rate) 7 58.264.30.062 Kidney-specific rate53.058.40.113 Liver-specific rate54.757.10.510 Heart-specific rate17.721.10.232 Lung-specific rate7.812.20.042 Pancreas-specific rate19.018.40.877 Donation rates adjusted for hospital characteristics AND notification rate.

26 Why Suppress Expected Rates Now? Statistics intended for quality improvement purposes. Lack of data for individual eligible deaths does not allow for substantive statistical adjustment. Data currently available for use in the models cannot currently be released to OPOs or the public. Important to assess the sources of variation in donation rates among the OPOs before finalizing the methods for assigning statistical significance to the comparisons.

27 Future Changes Donation rates will be adjusted when eligible death characteristics are collected:  Age  Race  Sex  Cause of death

28 Pilot Study of Individual Eligible Death Data 11 OPOs were selected as a representative sample. A multivariate model with age, race, sex, US citizenship, cause of death was highly significant (chi-square = 130, P < 0.0001), indicating that the factors were useful predictors of donation.

29 OPTN Collection of Individual Eligible Death Data Began January 9, 2008. Includes data on age, sex, race/ethnicity, and cause of death for each eligible death. Improves the modeling of expected conversion rates. Expect to begin using models after 1 year of data collection.

30 Additional Measures: Access to Transplant Components of variation: OPO and transplant center. OPO Table 6: percent transplanted by point in time. OPO Table 7: median waiting time. CSR Table 3: adjusted transplant rate.

31 Contact the SRTR www.srtr.org (877) 970-SRTR srtr@srtr.org

Download ppt "A Guide to the Scientific Registry of Transplant Recipients Organ Procurement Organization Reports www.srtr.org www.srtr.org."

Similar presentations

The Donor Most organ donors are accident victims that have suffered severe and eventually fatal injuries-often a severe head injury. Death is pronounced.

The Donor Most organ donors are accident victims that have suffered severe and eventually fatal injuries-often a severe head injury. Death is pronounced.
Organ Donation. A.No age limits – under 18 requires parent or guardian consent B.To donate, indicate on driver’s license and carry donor card C.Assure.

Organ Donation. A.No age limits – under 18 requires parent or guardian consent B.To donate, indicate on driver’s license and carry donor card C.Assure.
THE PATIENT’S JOURNEY TO TRANSPLANT AND BEYOND

THE PATIENT’S JOURNEY TO TRANSPLANT AND BEYOND
SRTR Transplant Benefit-Based Liver Allocation Robert M. Merion, MD, FACS OPTN/UNOS Liver Forum Atlanta, GA April 12, 2010.

SRTR Transplant Benefit-Based Liver Allocation Robert M. Merion, MD, FACS OPTN/UNOS Liver Forum Atlanta, GA April 12, 2010.
Supporting the Neonatal and Pediatric Donor Breakout Session A Presenters: Jeffrey Johnson, MD, LAC + USC Medical Center Mudit Mather, MD, Loma Linda University.

Supporting the Neonatal and Pediatric Donor Breakout Session A Presenters: Jeffrey Johnson, MD, LAC + USC Medical Center Mudit Mather, MD, Loma Linda University.
Northwestern University Feinberg School of Medicine New Trends in organ donation and Transplantation Juan Carlos Caicedo, MD FACS Director, Hispanic Transplant.

Northwestern University Feinberg School of Medicine New Trends in organ donation and Transplantation Juan Carlos Caicedo, MD FACS Director, Hispanic Transplant.
Characteristics Associated with Liver Graft Failure: The Concept of a Donor Risk Index American Journal of Transplantation 2006; 6: 783–790 S. Fenga, N.P.

Characteristics Associated with Liver Graft Failure: The Concept of a Donor Risk Index American Journal of Transplantation 2006; 6: 783–790 S. Fenga, N.P.
Issues In Organ Donation. The Data As of 10/6/09 there are 104,043 people on the US waiting list From January to July of 2009 16,677 transplants were.

Issues In Organ Donation. The Data As of 10/6/09 there are 104,043 people on the US waiting list From January to July of ,677 transplants were.
Bringing Others A Second Chance: The Pennsylvania Perspective presented by Serving western PennsylvaniaServing eastern Pennsylvania.

Bringing Others A Second Chance: The Pennsylvania Perspective presented by Serving western PennsylvaniaServing eastern Pennsylvania.
Organ and Tissue Donation – 2013 and Beyond Teresa Shafer, RN, MSN, CPTC Executive Vice President and Chief Operating Officer.

Organ and Tissue Donation – 2013 and Beyond Teresa Shafer, RN, MSN, CPTC Executive Vice President and Chief Operating Officer.
Liver and Intestinal Organ Transplantation Committee Spring 2014 Update.

Liver and Intestinal Organ Transplantation Committee Spring 2014 Update.
Nevada Donor Network The Donation Process. Who is Nevada Donor Network (NDN)? Federally designated, not-for-profit organ, tissue, and eye procurement.

Nevada Donor Network The Donation Process. Who is Nevada Donor Network (NDN)? Federally designated, not-for-profit organ, tissue, and eye procurement.
Donor Utilization: Making Use of a Precious Resource in Cardiac Transplant Jason W. Smith, MD Assistant Professor of Surgery The University of Washington.

Donor Utilization: Making Use of a Precious Resource in Cardiac Transplant Jason W. Smith, MD Assistant Professor of Surgery The University of Washington.
Lung Transplantation: What? Who? When? Marshall I. Hertz, MD University of Minnesota Medical School and Fairview-University Medical Center Medical Director,

Lung Transplantation: What? Who? When? Marshall I. Hertz, MD University of Minnesota Medical School and Fairview-University Medical Center Medical Director,
ORGAN DONATION www.organdonor.gov. Warm-Up # 1.What do you already know about organ donation? 2.Why do you think someone would say “no” to organ donation?

ORGAN DONATION Warm-Up # 1.What do you already know about organ donation? 2.Why do you think someone would say “no” to organ donation?
The SRTR Program- Specific Reporting Tools: Key Points.

The SRTR Program- Specific Reporting Tools: Key Points.
OPTN Living Donor Committee Non Action Items Connie Davis, MD June 26, 2012.

OPTN Living Donor Committee Non Action Items Connie Davis, MD June 26, 2012.
Physician Acceptance of New Medicaid Patients by State in 2011 Sandra Decker, Ph.D. National Center for Health Statistics NCHS National.

Physician Acceptance of New Medicaid Patients by State in 2011 Sandra Decker, Ph.D. National Center for Health Statistics NCHS National.
` Division of Transplantation/OSP/HRSA Allocation of Pancreata for Whole Organ and Islet Transplantation James Burdick, M.D. Director Health Resources.

` Division of Transplantation/OSP/HRSA Allocation of Pancreata for Whole Organ and Islet Transplantation James Burdick, M.D. Director Health Resources.
BC Jung A Brief Introduction to Epidemiology - IV ( Overview of Vital Statistics & Demographic Methods) Betty C. Jung, RN, MPH, CHES.

BC Jung A Brief Introduction to Epidemiology - IV ( Overview of Vital Statistics & Demographic Methods) Betty C. Jung, RN, MPH, CHES.

Similar presentations

Ads by Google